AVITA Medical, Inc.'s (NASDAQ:RCEL) Shift From Loss To Profit [Yahoo! Finance]
Avita Medical (NASDAQ:RCEL) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies [Yahoo! Finance]
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
Avita Medical (NASDAQ:RCEL) had its "hold" rating reaffirmed by analysts at Lake Street Capital.